432 results on '"De Lorenzis, E."'
Search Results
2. Consensus statement addressing controversies and guidelines on pediatric urolithiasis
3. AB1183 THE USE OF MYCOPHENOLATE MOFETIL IN LIMITED CUTANEOUS SYSTEMIC SCLEROSIS IS ASSOCIATED WITH A REDUCED RISK OF VASCULAR COMPLICATIONS REQUIRING PHARMACOLOGICAL INTERVENTION UPGRADES
4. POS1479-HPR TRAVEL DISTANCE TO TERTIARY HEALTHCARE REFLECTS DISEASE SEVERITY AND MEDICATION ACCESS IN SYSTEMIC SCLEROSIS PATIENTS: INSIGHTS FROM THE ITALIAN SPRING REGISTRY
5. OP0296 ARRHYTHMIC BURDEN, MYOCARDIAL MARKERS, AND LONG-TERM SURVIVAL IN DISTINCT CARDIAC MAGNETIC RESONANCE SUBSETS OF SYSTEMIC SCLEROSIS
6. POS0913 EVALUATION OF THE IMPLEMENTATION OF THE EULAR RECOMMENDATION CHECK LIST FOR TRANSPARENT AND COMPREHENSIVE REPORTING OF ULTRASOUND STUDIES IN RHEUMATIC AND MUSCULOSKELETAL DISEASES
7. AB1496 MICROCIRCULATION CHARACTERIZATION IN ANOREXIA NERVOSA PATIENTS WITH RAYNAUD’S PHENOMENON
8. OP0265 RITUXIMAB RETENTION RATE IN SYSTEMIC SCLEROSIS: A REAL-LIFE ITALIAN MULTICENTER STUDY
9. POS0826 PREDICTORS OF RESPONSE AND LONG-TERM EFFICACY AND SAFETY OF NINTEDANIB IN SYSTEMIC SCLEROSIS-INTERSTITIAL LUNG DISEASE: DATA FROM AN ITALIAN MULTICENTRE STUDY
10. POS1418 ESOPHAGEAL MUCOSAL EROSIONS CAN PREDICT THE DETERIORATION OF LUNG FUNCTION OVER A FOUR-YEAR FOLLOW-UP PERIOD AND LONG-TERM MORTALITY IN PATIENTS WITH INTERSTITIAL LUNG DISEASE ASSOCIATED WITH SCLERODERMA
11. OP0314 INTERFERON SCORE AS A NOVEL TRIAL ENRICHMENT TOOL TO PREDICT CLINICAL OUTCOMES IN PATIENTS WITH LIMITED CUTANEOUS SYSTEMIC SCLEROSIS
12. Vacuum-assisted mini-percutaneous nephrolithotomy is associated with lower rates of infectious complications compared to standard procedures in low-risk patients: A single-center experience
13. The impact of the surgical waiting list for transurethral resection of the prostate on patient’s clinical course: A single center investigation
14. Oncological outcomes and preoperative predictors of disease recurrence in upper tract urothelial carcinoma patients treated with distal ureterectomy: Results from a large national cohort
15. Stone cultures performed during PCNL could accurately predict post-operative septic complications: A single tertiary centre experience
16. Feasibility and relevance of urine culture during stone fragmentation in patients undergoing percutaneous nephrolithotomy and retrograde intrarenal surgery: a prospective study
17. Chronic related group classification system as a new public health tool to predict risk and outcome of COVID-19 in patients with systemic rheumatic diseases: A population-based study of more than forty thousand patients
18. POS1326 LONG TERM TREATMENT WITH RITUXIMAB IN PROGRESSIVE SYSTEMIC SCLEROSIS: A MONOCENTRIC RETROSPECTIVE STUDY
19. POS0461 AN INCREASE IN ULTRASOUND JOINT INFLAMMATION OCCURS WHEN ANTI-CCP POSITIVE AT-RISK INDIVIDUALS WITH SUBCLINICAL SYNOVITIS PROGRESS TO INFLAMMATORY ARTHRITIS
20. POS1336 MRI DIGITAL ARTERY VOLUME INDEX (DAVIX©) AS QUANTITATIVE, CONTINUOUS IMAGING OUTCOME MEASURE OF VASCULAR DISEASE IN SYSTEMIC SCLEROSIS
21. AB0842 HIGH BRONCHOALVEOLAR FLUID NEUTROPHILS INDEPENDENTLY PREDICT 15-YEAR MORTALITY IN SCLERODERMA PATIENTS WITH INTERSTITIAL LUNG DISEASE NAIVE TO IMMUNOSUPPRESSANT
22. POS1257 CCL24 SERUM CONCENTRATION PREDICTS BOTH VASCULAR AND FIBROTIC COMPLICATIONS IN SYSTEMIC SCLEROSIS
23. POS0948 PATTERNS OF DISEASE PROGRESSION IN SYSTEMIC SCLEROSIS PATIENTS WITH INTERSTITIAL LUNG DISEASE
24. AB0881 CLINICAL TRAJECTORIES OF MULTIFACTORIAL HAND FUNCTION DETERIORATION IN SYSTEMIC SCLEROSIS
25. OP0124 A REDUCED ULTRASOUND SCANNING PROTOCOL OF 3 JOINTS BILATERALLY IMPROVES PREDICTION OF INFLAMMATORY ARTHRITIS PROGRESSION IN ANTI-CCP ANTIBODIES POSITIVE INDIVIDUALS WITH MUSCULOSKELETAL SYMPTOMS
26. Live surgery: highly educational or harmful?
27. Real-life efficacy and safety of nintedanib in systemic sclerosis-interstitial lung disease: data from an Italian multicentre study
28. Survival and prognostic factors from a multicentre large cohort of unselected Italian systemic sclerosis patients
29. Lung vascular changes as biomarkers of severity in systemic sclerosis-associated interstitial lung disease
30. Are all people with diabetes and cardiovascular risk factors or microvascular complications at very high risk? Findings from the Risk and Prevention Study
31. Percutaneous microwave ablation has similar perioperative and oncologic outcomes than cryoablation for the treatment of T1a renal masses: results from a cross-sectional study
32. Comparison between spinal and general anesthesia in patients undergoing endoscopic enucleation of the prostate: is there a clinical advantage?
33. Changes in renal function after nephroureterectomy for upper urinary tract carcinoma: analysis of a large multicenter cohort (radical nephroureterectomy outcomes (RANEO) research consortium)
34. Urologists are optimistic surgeons: prevalence and predictors of discordance between intraoperative stone-free rate and cross-sectional imaging evaluation after vacuum-assisted mini-percutaneous nephrolithotomy
35. AB0700 HIGH BRONCHOALVEOLAR FLUID NEUTROPHILS INDEPENDENTLY PREDICT 15-YEAR MORTALITY IN SCLERODERMA PATIENTS WITH INTERSTITIAL LUNG DISEASE NAIVE TO IMMUNOSUPPRESSANTS
36. AB0698 IMPACT OF ILOPROST WITHDRAWAL IN SCLERODERMA PATIENTS DUE TO COVID-19 PANDEMIC
37. AB0142 EVIDENCE OF TYPE I INTERFERON ACTIVATION DURING VASCULAR MANIFESTATIONS OF SYSTEMIC SCLEROSIS
38. POS0890 NINTEDANIB REAL-LIFE EFFICACY AND SAFETY IN SYSTEMIC SCLEROSIS (SSc)-INTERTISTIAL LUNG DISEASE (ILD): AN ITALIAN MULTICENTRE PRELIMINARY STUDY.
39. POS1251 INCIDENCE AND OUTCOMES OF SARS-CoV-2 INFECTION IN PATIENTS WITH SYSTEMIC AUTOIMMUNE RHEUMATIC DISEASES: A POPULATION-BASED STUDY OF MORE THAN FOUR MILLION INHABITANTS IN THE LAZIO ITALIAN REGION
40. AB0704 LOW BODY MASS INDEX IN PATIENTS WITH RAYNAUD PHENOMENON IS ASSOCIATED WITH ENLARGED CAPILLARIES AND REDUCTION IN CAPILLARY DENSITY AT NAILFOLD VIDEOCAPILLAROSCOPY
41. POS0876 SERUM INTERFERON SCORE PREDICTS SEVERITY OF PATIENT REPORTED HAND DISABILITY IN SYSTEMIC SCLEROSIS
42. POS0887 CHORIORETINAL MICROVASCULAR INVOLVEMENT IN SYSTEMIC SCLEROSIS
43. Trifecta achievement in vacuum assisted mini-percutaneous nephrolithotomy: A single center experience
44. A new tool for reporting complications after percutaneous nephrolithotomy: The comprehensive complication index
45. Which stones should be treated by vacuum assisted mini-PCNL?
46. Urologists are optimistic surgeons: Prevalence and predictors of discordance between intraoperative stone free rate and cross-sectional imaging evaluation after vacuum-assisted mini-percutaneous nephrolithotomy
47. The comprehensive complication index as a tool for reporting the burden of complications after percutaneous nephrolithotomy: Is it time to leave the Clavien-Dindo classification behind?
48. Transperineal interstitial laser ablation of the prostate as a minimally-invasive and effective therapeutic option for benign prostatic hyperplasia
49. Clinical and time-related predictors of sepsis in patients with obstructive uropathy due to ureteral stones in the emergency setting
50. Litiasi delle vie urinarie
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.